TDOX Clinic has officially been recognized by ASEAN Records for its groundbreaking contributions in the field of regenerative medicine. The clinic has achieved the distinguished title: “ASEAN’s First Private Clinic with In-House cGMP-Certified Regenerative Medicine Laboratory to Conduct a Preclinical Study on Exosome-Based MSC Therapy for the Treatment of Metabolic Syndrome.”
This milestone recognizes TDOX Clinic as a trailblazer in the ASEAN region, combining clinical practice with advanced regenerative science to address one of the world’s most pressing health concerns—metabolic syndrome.
Pioneering Research in Exosome-Based MSC Therapy
Metabolic syndrome is a complex and growing health issue linked to obesity, insulin resistance, hypertension, and cardiovascular disease. TDOX Clinic is the first private clinic in ASEAN to initiate a preclinical study using Mesenchymal Stem Cell (MSC)-derived exosomes, aiming to develop effective, cell-free regenerative treatments for patients with metabolic-related disorders.
Housed within TDOX’s medical facility is a state-of-the-art, cGMP-certified regenerative medicine laboratory, enabling the clinic to safely and ethically conduct cutting-edge research and therapy development under one roof.
A Clinical Milestone for ASEAN Healthcare
This ASEAN Records achievement affirms TDOX’s commitment to clinical excellence, regulatory compliance, and innovation in cellular therapies. It marks a significant step forward in the regional advancement of precision medicine and non-invasive treatment alternatives.
“We are deeply honored to receive this recognition from ASEAN Records. This achievement not only validates our commitment to scientific innovation but also our dedication to improving lives through the future of medicine,” said Dato Choi, CEO of TDOX (M) Sdn. Bhd.
About TDOX Clinic
TDOX Clinic is a Malaysia-based premier regenerative medicine center that combines advanced diagnostics, personalized treatment plans, and cutting-edge stem cell therapies. By integrating research, clinical application, and biotechnology under one roof, TDOX is redefining how chronic and degenerative conditions are managed in the region.
Its multidisciplinary approach leverages cell therapy, exosome science, and metabolic health management, providing patients with innovative care based on scientific evidence and regulated best practices.
Learn more at: [www.tdox.my]